Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: CombiGene comments on the discontinued CGT2 project

CombiGene has terminated the preclinical development of the lipodystrophy project CGT2 after the data did not prove to be convincing enough to justify its continuation. According to the company, the discontinuation of the project means that resources can now be freed up for the COZY pain project in particular.Read the full interview with Peter Ekolind at biostock.se: https://www.biostock.se/en/2024/02/combigene-comments-on-the-discontinued-cgt2-project/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Gasum to invest in a new biogas plant in Borlänge, Sweden, to bring more renewable energy to the market

Gasum has decided to invest in a new biogas plant in Borlänge, Sweden. The investment decision is the next step in Gasum’s plan to build five large-scale biogas plants in Sweden. It also promotes Gasum’s strategic goal of increasing Nordic biogas availability significantly in coming years.Gasum continues its plan to increase the availability of biogas by investing over 62 million euros in the construction of a biogas plant in Borlänge, Sweden. The project has been granted a subsidy of 15 million euros from the Swedish Environmental Protection Agency’s Klimatklivet investment program.

Mölnlycke’s science-based targets validated

· The Science Based Targets initiative (SBTi) has validated that the greenhouse gas (GHG) emission reduction targets submitted by Mölnlycke Health Care conform to the SBTi criteria and recommendations and are aligned with the 1.5°C trajectory · This is the next step towards Mölnlycke’s ambition to help decarbonise healthcareGothenburg, 2 February 2024: Today, Mölnlycke Health Care, a world leading MedTech company, announces that its near-term GHG emission reduction targets submitted to the SBTi have been validated and deemed to be compliant with all applicable requirements.

Crunchfish intends to divest its gesture interaction business

Crunchfish together with its Board of Directors have undertaken a strategic review of the business, resulting in a decision to explore a divestment of the Crunchfish Gesture Interaction subsidiary. The Board of Directors recognizes that it will achieve a better position for further growth in a new organizational setting. Simultaneously, Crunchfish will continue to build on the momentum and development of the Digital Cash business, as it is expected to have the strongest potential going forward.Crunchfish and its Board of Directors have in a strategic review concluded that the company should

US Government Agency Extends Product Support Agreement with Irisity

Irisity AB (publ), a provider of AI-driven video data management software, reports a renewal with ongoing upgrades for an enterprise security contract with a US government agency. It is an Annual Recurring Revenue (ARR) contract, marking the third year of the agency relying on this deployment, provided in partnership with a US-based integrator.FOR IMMEDIATE RELEASE     US Government Agency Extends Product Support Agreement with Irisity   Gothenburg, Sweden – February 2, 2024 – Irisity AB (publ), a provider of AI-driven video data management software, reports a renewal with

Sandvik completes the acquisition of pro-micron GmbH

Sandvik has completed the previously announced acquisition of pro-micron GmbH, a German-based supplier of sensorised tools and automation software. The company will be reported in Sandvik Coromant, a division within Sandvik Manufacturing and Machining Solutions. Pro-micron, founded in 2002 has around 56 employees and is headquartered in Kaufbeuren, Bavaria, Germany. In 2022, the company generated revenues of about SEK 88 million. The impact on Sandvik’s EBITA margin and earnings per share will be limited. Stockholm, February 2, 2024Sandvik AB For further information, contact

Dedicare launches Dedicare International – innovative offering for Nordic healthcare professionals to work abroad

Dedicare, the Nordic region’s largest recruitment and staffing provider in healthcare, life science and social work, announces today the launch of its groundbreaking concept – Dedicare International. This initiative targets healthcare professionals in the Nordic region aspiring to work internationally and signifies a strategic milestone in Dedicare's growth journey towards becoming one of Europe's leading recruitment and staffing providers.    Dedicare International specifically targets nurses, doctors, and social workers in the Nordic region who are interested in international career

Publication of United Bankers Plc’s 2023 Financial Statements Bulletin and invitation to result presentation on 16 February 2024

United Bankers Plc PRESS RELEASE 2 February 2024 at 10:00 EET   Publication of United Bankers Plc’s 2023 Financial Statements Bulletin and invitation to result presentation on 16 February 2024   United Bankers Plc will publish its Financial Statements Bulletin for the period January-December 2023 on Friday 16 February 2024 at approximately 9.00 am. The Financial Statements Bulletin will be available on the company’s website at www.unitedbankers.fi  after publishing. Patrick Anderson, CEO, will present the result to

Hemnet announces the finalists for Guldhemmet 2023

On March 7 the fifth edition of Hemnet’s property gala Guldhemmet will take place. The jury has reviewed and evaluated all the nominations submitted and selected a total of 21 finalists.  The winners will be announced at the Guldhemmet gala, which recognises the Swedish housing industry’s premier profiles and strongest efforts.   Guldhemmet is an initiative from Hemnet, which gathers and highlights the best achievements of the housing industry from the past year, now for the fifth consecutive year. The gala will take place on March 7 in Vinterträdgården at Grand Hôtel in Stockholm and

Tails of Romance: Study Finds Pets Playing Matchmaker for One Third of Owners

As Valentine’s Day approaches and many people prepare for a day filled with love, some singletons may wonder how to meet someone new. Dogs may be known for being man’s best friend, but they’re also statistically proven to improve their owner's social life. Perhaps even leading to a paw-fect match, according to a recent study which found that one in three dog owners have met a new partner or friend through their pet.     The research by leading animal insurer,  Agria Pet Insurance , shows that pets can help to create

Aquaporin announces changes in Executive Management Team

Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, Company registration no.: DK28315694 Company announcementNo. 02/2024 - Inside Information · Founder and Chief Innovation Officer, Peter Holme Jensen, to step down and be proposed as member of the Board of Directors at forthcoming Annual General Meeting · Current Senior VP, Deep Tech, Torsten Høybye Bak Regueira, appointed Chief Technology Officer Copenhagen, Denmark, February 2, 2024 – Aquaporin A/S (ticker: AQP) (“Aquaporin” or the “Company”), an innovative water technology company dedicated to

Flowscape wins deal in Canada

A global consulting company has chosen Flowscape smart office solution to support its hybrid way of working in an office in Canada. The order value amounts to CAD 65,000 (SEK 505,000) in the first year and thereafter CAD 18,000 (SEK 154,000) annually recurring."It's great that we continue to win business in North America. We have been working with this company for some time and they now choose to install a Flowscape system at yet another office in Canada. Among other things, the customer asked for an efficient solution for desk bookings 

BioStock: Curasight gets first milestone payment from Curium

The prostate cancer partnership with Curium marks the most pivotal moment for the radiopharmaceutical focused biotech company Curasight to date. Now, the company has announced a first milestone payment under the deal, for the validation of GMP manufacturing of finished product. BioStock reached out to CEO Ulrich Krasilnikoff to learn more.Read the full article at biostock.se: https://www.biostock.se/en/2024/02/curasight-gets-first-milestone-payment-from-curium/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Results of Annual General Meeting

TECTONIC GOLD PLC (“Tectonic Gold” or the “Company”) Results of Annual General MeetingTectonic Gold plc (TDIM: TTAU) is pleased to announce that all resolutions proposed to shareholders at the Company's Annual General Meeting held earlier today were duly passed. For further information, please contact: Tectonic Gold plc +61 2 9241 7665 Brett Boynton Sam Quinn www.tectonicgold.com@tectonic_goldAQSE Corporate Adviser and Broker +44 20 3005 5004 VSA Capital Limited Andrew Raca – Corporate Finance Andrew Monk – Corporate Broking Ends

Plejd's nominating committee proposes Magnus Zederfeldt as a new board member

The nominating committee of Plejd AB has decided to nominate Magnus Zederfeldt as a new board member at the annual meeting on April 23, 2024. Magnus Zederfeldt has over 13 years of experience from Axis, where he held a central role in developing their international growth until 2022. Magnus extensive experience is expected to augment the current board, which includes Ylwa Karlgren, Erik Calissendorff, Nico Jonkers, Halldora von Koenigsegg, and Anders Persson, all proposed for re-election. Complete details about the committee's proposal will be provided in connection with the notice for the

Invitation for presentation of Pricer’s interim report for the fourth quarter 2023

Pricer AB will present its interim report for the fourth quarter 2023 in a webcast on February 8 at 13.00 CET.According to the financial calendar, Pricer will publish the report for the fourth quarter 2023 on Thursday, February 8 at approximately 8.30 am CET. Pricer hereby invites to a presentation of the report on the same day. Magnus Larsson, President and CEO, and Susanna Zethelius, CFO, will present the report and answer questions. Date: February 8, 2024 Time: 13.00 CET Link to the webcast: Pricer AB, Webcast, Q4, 2023 | Financial Hearings 

LEAX CEO leaves his position

Tony Nicol is leaving his role as President and CEO for a new job outside of LEAX. At the same time, Tony will move back home to Canada.Tony Nicol joined LEAX in 2020 and has been President and CEO of LEAX since 2021. To ensure a safe handover, Tony will continue to work at LEAX during the spring of 2024, while the recruitment of a replacement is now underway. "I would like to thank Tony for his valuable contribution as President and CEO of LEAX. Through his leadership and commitment, Tony has played an important role in successfully developing LEAX in recent years. Tony's experience has

1Vision Biogas announces a mandatory cash offer to the shareholders of Biokraft and publishes offer document

The Offer is not being made, and this press release may not be released, distributed or published, in whole or in part, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which the making of the Offer, the release, distribution or publication of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer

Konecranes Plc’s Board of Directors convenes the Annual General Meeting 2024

KONECRANES PLC STOCK EXCHANGE RELEASE FEBRUARY 2, 2024 at 09:30 am EET   Konecranes Plc’s Board of Directors convenes the Annual General Meeting 2024   Notice to the Annual General Meeting   Notice is given to the shareholders of Konecranes Plc ("Konecranes" or the "Company") to the Annual General Meeting to be held on Wednesday 27 March 2024 at 10.00 am EET at Hyvinkääsali (address: Kauppatori 1, FI-05800 Hyvinkää, Finland). Reception of persons registered for the meeting and distribution of voting tickets at the meeting venue will commence at 9.15 am EET.

United Bankers Plc’s shareholders’ proposals to the Annual General Meeting 2024

United Bankers Plc STOCK EXCHANGE RELEASE 2 February 2024 at 9:30 EET     United Bankers Plc’s shareholders’ proposals to the Annual General Meeting 2024 United Bankers Plc’s shareholders representing approximately 40 per cent of all shares and votes in the Company (31 December 2023) have submitted a proposal to the Annual General Meeting to be held on 22 March 2024 for the number of members of the Board of Directors, the composition of the Board of Directors and its remuneration.   Proposal for the number of members and composition of the Board of Directors The

Diabetic Foot Screening is introduced at Skåne University Hospital, Lund

The Diabetes Clinic, Skåne University Hospital in Lund has decided to introduce Diabetic Foot Screening as standard in the clinical operations, for regular control of nerve damage in the feet of people living with diabetes.The diabetes clinic at Skåne University Hospital in Lund uses the VibroSense Meter® II and introduces the Diabetic Foot Screening examination as standard in its clinical operations. At the clinic, the methodology will be used in foot examinations of people living with diabetes. "The method adds an increased opportunity for earlier diagnosis and treatment, which we hope

Last day of trading in warrants of series TO 6 B is today February 2, 2024

Lund, Sweden - Today, February 2, 2024, is the last day of trading in warrants of series TO 6 B, which were issued in connection with Clinical Laserthermia Systems AB's ("CLS" or the "Company") preferential rights issue of units resolved by the extraordinary general meeting on June 8, 2023. The exercise period runs until and including February 6, 2024.Each warrant of series TO 6 B entitles the holder to subscribe for one (1) new B-share in CLS at a price of SEK 0.10 per share during the exercise period that started on January 23, 2024 and runs until and including February 6, 2024.

Year-end report Rejlers AB January – December 2023

October - December · Net sales increased by 14.4% to SEK 1,132.6 million (990.2) · Organic sales growth amounted to 3.2% (8.6) · EBITA amounted to SEK 90.5 million (91.8), and the EBITA margin was 8.0% (9.3), negatively impacted by restructuring costs of SEK 10.0 million and one working day less than in the same quarter last year · Excluding items affecting comparability, EBITA increased to SEK 100.5 million and the EBITA margin amounted to 8.9% · Operating profit (EBIT) amounted to SEK 71.2 million (79.6), impacted by acquisition expenses of SEK 3.7 million (0.1), with

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseFebruary 2, 2024 at 9.30 am EETRepurchase of Outokumpu’s own shares On February 1, 2024, Outokumpu has completed repurchases of its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |76,166 |3.9911

There are no items matching the current filter
There are no more items matching the current filter
Back to top